TNF and rheumatoid arthritis: Systemic inhibitors of TNF such as etanercept (a soluble TNF receptor), infliximab and adalimumab (anti‐TNF antibodies) have been approved for the treatment of psoriasis and RA (Meier, Frerix, Hermann, & Muller‐Ladner, 2013).